jˈuːzɪŋ ˈæntɪbˌɑːdiz spəsˈɪfɪk fɚðə tɹˈɛpoʊnmə pælˈɪdəm spˈiːsiːz, sˈʌtʃ tˈɛsts wʊd biː ɐsˈuːmd təbi mˈoːɹ spəsˈɪfɪk ðɐn nˈɑːntɹˈɛpoʊnməl tˈɛstɪŋ sˈʌtʃ ɐz vˌiːdˌiːˌɑːɹɹˈɛl bˌʌt hɐvbɪn ʃˈoʊn ɹᵻpˈiːɾᵻdli təbi sˈɛnsᵻtˌɪv bˌʌt nˌɑːt spəsˈɪfɪk fɚðə dˌaɪəɡnˈoʊsɪs ʌv nˈʊɹɹəsˌɪfɪliz ɪn sɚɹˌiːbɹəspˈaɪnəl flˈuːɪd sˌiːˌɛsˈɛf.
Using antibodies specific for the Treponema pallidum species, such tests would be assumed to be more specific than non-treponemal testing such as VDRL but have been shown repeatedly to be sensitive but not specific for the diagnosis of neurosyphilis in cerebrospinal fluid (CSF).